Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Intranasal Dexmedetomidine-esketamine Administration on Postoperative Pain in Pediatric Patients Undergoing Adenotonsillectomy
NCT07479602Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Apr 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and esketamine in postoperative pain (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Area under curve of pain intensity within 48 hours after surgery. Started Apr 2026; status: recruiting.
02
Drugs
dexmedetomidineesketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07479602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07479602.